Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny G Low

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Plos Neglected Tropical Diseases|August 18, 2022
Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illnessShirin Kalimuddin, Yii Ean Teh, Liang En Wee, et al.
Trials|April 16, 2015
The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trialJenny G Low, Limin Wijaya, Greg K Y Li, et al.
Frontiers in Immunology|March 27, 2023
An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trialShirin Kalimuddin, Yvonne F Z Chan, October M Sessions, et al.
Vaccine|January 26, 2017
An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteersLimin Wijaya, Christine Y L Tham, Yvonne F Z Chan, et al.
JCI Insight|September 28, 2021
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccineRoland Tschismarov, Raphaël M Zellweger, Min Jie Koh, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2024
IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled TrialJenny G Low, Helen M Oh, Yee-Sin Leo, et al.
Plos One|November 27, 2013
Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control studyTun-Linn Thein, Yee-Sin Leo, Dale A Fisher, et al.
Influenza and Other Respiratory Viruses|October 1, 2019
Genetic diversity of respiratory enteroviruses and rhinoviruses in febrile adults, Singapore, 2007-2013Martin Linster, Celeste Donato, Marcus G Mah, et al.
BMC Infectious Diseases|May 17, 2011
Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective studyYee-Sin Leo, Tun L Thein, Dale A Fisher, et al.
Ebiomedicine|March 10, 2021
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolutionEugenia Z Ong, Shirin Kalimuddin, Wen Chong Chia, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Plos Neglected Tropical Diseases|August 18, 2022
Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illnessShirin Kalimuddin, Yii Ean Teh, Liang En Wee, et al.
Trials|April 16, 2015
The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trialJenny G Low, Limin Wijaya, Greg K Y Li, et al.
Frontiers in Immunology|March 27, 2023
An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trialShirin Kalimuddin, Yvonne F Z Chan, October M Sessions, et al.
Vaccine|January 26, 2017
An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteersLimin Wijaya, Christine Y L Tham, Yvonne F Z Chan, et al.
JCI Insight|September 28, 2021
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccineRoland Tschismarov, Raphaël M Zellweger, Min Jie Koh, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2024
IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled TrialJenny G Low, Helen M Oh, Yee-Sin Leo, et al.
Plos One|November 27, 2013
Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control studyTun-Linn Thein, Yee-Sin Leo, Dale A Fisher, et al.
Influenza and Other Respiratory Viruses|October 1, 2019
Genetic diversity of respiratory enteroviruses and rhinoviruses in febrile adults, Singapore, 2007-2013Martin Linster, Celeste Donato, Marcus G Mah, et al.
BMC Infectious Diseases|May 17, 2011
Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective studyYee-Sin Leo, Tun L Thein, Dale A Fisher, et al.
Ebiomedicine|March 10, 2021
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolutionEugenia Z Ong, Shirin Kalimuddin, Wen Chong Chia, et al.
Pageof 6